000046553 000__ 01038cam\a22003735i\4500
000046553 001__ 46553
000046553 003__ SzGeWIPO
000046553 005__ 20230509110041.0
000046553 006__ m\\\\eo\\d\\\\\\\\
000046553 007__ cr bn |||m|||a
000046553 008__ 221017s2021\\\\nyu\\\\\o\\\\\000\0\eng\d
000046553 035__ $$a(OCoLC)1348116717
000046553 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046553 041__ $$aeng
000046553 24500 $$aGermany: Pemetrexed II.
000046553 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2021
000046553 300__ $$a1 online resource
000046553 336__ $$atext$$2rdacontent
000046553 337__ $$acomputer$$2rdamedia
000046553 338__ $$aonline resource$$bcr$$2rdacarrier
000046553 4901_ $$aInternational Review of Intellectual Property Law & Competition Law,$$x0018-9855 ;$$vVolume 52, Issue 4
000046553 542__ $$fhttps://1.next.westlaw.com/Copyright
000046553 588__ $$aCrossref
000046553 590__ $$aPublished online: 2021
000046553 650_0 $$aIntellectual property.
000046553 650_4 $$aPatents$$zGermany
000046553 650_4 $$aPharmaceuticals
000046553 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000046553 7731_ $$wIIC
000046553 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vIIC 2021, 52(4), 477-493
000046553 85641 $$uhttps://www.westlaw.com/Document/I3E0AB8E0B31411EBBFCFDD11DD954599/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046553 904__ $$aArticle
000046553 980__ $$aIIC